|
Nov 28
|
TC BioPharm (TCBP) Falls Despite FDA Clearing IND for AML Drug
|
|
Nov 27
|
TC BioPharm Announces FDA Clearance of Phase 1B IND for TCB-008 in Acute Myeloid Leukemia
|
|
Apr 26
|
TC BioPharm Increases Allogeneic Car and Partnering Focus for Advancement of TCB-008
|
|
Feb 23
|
TC BioPharm Announces Dr. Mike Leek as Chief Technology Officer
|
|
Feb 21
|
TC BioPharm Announces Publication of Paper in AML Research Highlighting the Company's Development of Allogeneic Gamma-Delta T cell Therapies
|